ORKA Stock Analysis: Buy, Sell, or Hold?
ORKA - Oruka Therapeutics, Inc. Common Stock
$83.40
-1.98 (-2.32%)
▼
5d:
+21.12%
30d:
+42.1%
90d:
+100.67%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When ORKA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ORKA is 15.7% above its trading range ($72.07). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ORKA is 15.7% above its trading range ($72.07). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ORKA is currently trading at $83.40, which is considered extended relative to its 30-day fair value range of $56.10 to $72.07.
Technical Outlook: Technically, ORKA is in a strong uptrend. Immediate support is located at $62.55, while resistance sits at $88.83.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $142.17 (+66.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ORKA is in a strong uptrend. Immediate support is located at $62.55, while resistance sits at $88.83.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $142.17 (+66.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$56.10 -
$72.07
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
40.5%
All Signals
- BEARISH: Price significantly overextended (+15.7% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 66.5% below Wall St target ($142.17)
Trading Range Analysis
30-Day Trading Range
$56.10 -
$72.07
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$62.55
Resistance Level
$88.83
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-34.68
Wall Street Target
$142.17
(+66.5%)
Share & Embed Analysis
Last updated: June 23, 2026 4:37 PM ET
Data refreshes hourly during market hours. Next update: 5:37 PM
Data refreshes hourly during market hours. Next update: 5:37 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ORKA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Joana Goncalves
SELL
7000 shares
2026-04-15
Arjun Agarwal
SELL
395 shares
2026-03-16
Joana Goncalves
SELL
7641 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 67 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$105 | 64 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 65 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 65 BUY |
